ABOS - Acumen Pharmaceuticals GAAP EPS of -$0.24 beats by $0.03
2023-11-13 07:10:00 ET
More on Acumen Pharmaceuticals
- Navigating Acumen's Alzheimer's Risk And Reward
- Acumen Pharmaceuticals: Novel Alzheimer's Molecule With Positive Early Data
- Halozyme, Acumen enter collaboration for Alzheimer's drug candidate
- Seeking Alpha’s Quant Rating on Acumen Pharmaceuticals
- Historical earnings data for Acumen Pharmaceuticals
For further details see:
Acumen Pharmaceuticals GAAP EPS of -$0.24 beats by $0.03